Literature DB >> 10892594

Direct analysis of artemisinin in plasma and saliva using coupled-column high-performance liquid chromatography with a restricted-access material pre-column.

T Gordi1, E Nielsen, Z Yu, D Westerlund, M Ashton.   

Abstract

A previously established HPLC system with post-column derivatization for the analysis of artemisinin was coupled to an ADS (alkyl-diol silica) pre-column, allowing direct and repetitive injection of protein-rich fluids such as plasma. The limit of quantitation for 100 microl of plasma was 10 ng/ml (CV=10.5%) while concentrations down to 2 ng/ml could be quantified for 1.00 ml saliva samples (CV=11.1%). The system was linear in the tested range of 10-2000 ng/ml for plasma and 2-240 ng/ml for saliva samples, respectively. This paper introduces coupled column HPLC as a simplified method for the routine analysis of artemisinin in biological fluids.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10892594     DOI: 10.1016/s0378-4347(00)00156-0

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  6 in total

1.  Semi-mechanistic pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of artemisinin.

Authors:  Toufigh Gordi; Rujia Xie; William J Jusko
Journal:  Br J Clin Pharmacol       Date:  2005-12       Impact factor: 4.335

2.  Pharmacokinetics of artesunate alone and in combination with sulfadoxine/pyrimethamine in healthy Sudanese volunteers.

Authors:  Kamal M Matar; Abdelmoneim I Awad; Sakina B Elamin
Journal:  Am J Trop Med Hyg       Date:  2014-03-10       Impact factor: 2.345

3.  A semiphysiological pharmacokinetic model for artemisinin in healthy subjects incorporating autoinduction of metabolism and saturable first-pass hepatic extraction.

Authors:  Toufigh Gordi; Rujia Xie; Nguyen V Huong; Dinh X Huong; Mats O Karlsson; Michael Ashton
Journal:  Br J Clin Pharmacol       Date:  2005-02       Impact factor: 4.335

4.  Artemisinin pharmacokinetics and efficacy in uncomplicated-malaria patients treated with two different dosage regimens.

Authors:  Toufigh Gordi; Dinh Xuan Huong; Trinh Ngoc Hai; Nguyen Thi Nieu; Michael Ashton
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

5.  Artemisinin and CYP2A6 activity in healthy subjects.

Authors:  Sara Asimus; Trinh Ngoc Hai; Nguyen Van Huong; Michael Ashton
Journal:  Eur J Clin Pharmacol       Date:  2007-12-07       Impact factor: 2.953

6.  Quantification of artemisinin in human plasma using liquid chromatography coupled to tandem mass spectrometry.

Authors:  N Lindegardh; J Tarning; P V Toi; T T Hien; J Farrar; P Singhasivanon; N J White; M Ashton; N P J Day
Journal:  J Pharm Biomed Anal       Date:  2008-12-24       Impact factor: 3.935

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.